Efficacy and tolerability of tirzepatide in patients with type 2 diabetes: a 12-week randomized, double-blind, placebo-controlled study
CLA has been one of the most extensively studied fatty acids in the field of body composition and metabolic wellness nutrition
Today, Novo Nordisk estimates that just under 20 million people are treated with GLP-1 drugs.4 Given a well-stocked pipeline, a substantial global addressable population (the obese population alone is projected to exceed 1.2 billion by 20305), and in light of the very beneficial clinical profile of these drugs, it is plausible that over 100 million patients worldwide will be treated with GLP-1s in the near future
The matter only becomes important if, once recovery is complete, a lasting, patterned form of hair loss emerges
Injecting them within 60 minutes of a meal blunts growth hormone release by up to 80% (Nass et al., J Clin Endocrinol Metab, 2008)